查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
靜脈器材市場：依產品類型、最終用戶分類：全球機會分析與產業預測，2023-2032年
市場調查報告書
商品編碼
1365617

靜脈器材市場：依產品類型、最終用戶分類：全球機會分析與產業預測，2023-2032年

Intravenous Equipment Market By Product Type (IV catheters, Infusion pumps, Administration sets, Needleless connectors, Others), By End User (Hospitals & clinics, Homecare settings, Others): Global Opportunity Analysis & Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

根據Allied Market Research最新報告《靜脈器材市場》，2022年靜脈器材市場估值為150億美元，2023年至2032年年複合成長率為5.9%，2032年將達到267億美元。預計它將達到。

靜脈器材市場-IMG1

靜脈 (IV) 設備是用於靜脈治療的儀器和設備，靜脈治療是一種透過靜脈將液體、藥物和營養物質直接輸送到患者血液中的醫療程序。靜脈治療通常用於多種目的，包括供給、給藥、輸血和營養供給。靜脈注射設備的範例包括插入靜脈以獲得通路的針頭和導管、將靜脈輸液袋和容器連接到患者的軟管，控制和調節流量以確保準確輸注的電子設備、輸液泵等。

推動靜脈器械市場成長的主要要素是慢性病患者數量的增加、老年人口的增加以及靜脈器械技術的不斷進步。癌症、糖尿病、心血管疾病和感染疾病等慢性病罹患率的上升推動了靜脈注射治療的需求。靜脈注射提供了一種直接有效的藥物、液體和營養物質的給藥方式，使其成為慢性病患者的重要治療方法。此外，世界人口結構發生重大變化，老年人口迅速增加。老年人更容易患上慢性疾病，需要經常住院和治療。靜脈治療在為老年患者提供支持性護理方面發揮著重要作用。因此，老年人口的增加促進了靜脈注射裝置市場的成長。

此外，靜脈注射裝置技術的不斷進步提高靜脈注射治療的安全性、準確性和易用性。智慧輸液幫浦、整合連接解決方案和無針輸液系統等創新提高了藥物輸送的效率和準確性，降低了用藥錯誤的風險，並改善了患者的治療效果。此外，醫療專業人員和患者越來越意識到靜脈治療的好處，包括更快的藥物吸收、精確的藥物傳遞和提高患者的依從性。因此，越來越多的醫療保健專業人員將靜脈注射治療涵蓋他們的治療計劃，增加了對靜脈注射設備的需求。

此外，由於許多國家投入大量資源加強醫療保健基礎設施和增加獲得優質醫療服務的機會，醫療保健支出持續增加。醫療保健支出的增加包括購買靜脈注射設備等基本醫療設備，以滿足對先進患者照護不斷成長的需求，推動市場成長。此外，部門和重症監護病房越來越依賴靜脈注射治療來快速穩定患者病情並給藥救生藥物和液體。全球醫療緊急情況和創傷病例數量的不斷增加，大幅增加了這些環境中對靜脈注射設備的需求。靜脈注射裝置在快速有效地提供重要治療並確保重症監護環境中的最佳患者治療效果方面發揮關鍵作用。

靜脈注射設備市場依產品類型、最終用戶和地區細分。依產品類型分類，市場分為靜脈導管、輸液幫浦、給藥裝置、無針連接器等。此外，給藥裝置分為溶液給藥裝置和血液給藥裝置。依最終使用者分為醫院/診所、居家醫療等。依地區分類，市場分為北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、歐洲其他地區）、亞太地區（日本、中國、澳洲、印度、韓國、其他地區） 、LAMEA (巴西、南非、沙烏地阿拉伯和LAMEA其他地區)。在全球靜脈器械市場營運的主要企業有 Becton、Dickinson and Company、B. Braun SE、ICU Medical, Inc.、vygon、Baxter International Inc.、Teleflex Incorporated、3M Company、AngioDynamics, Inc.、Terumo Corporation、和Poly Medicure Ltd.。主要企業採取產品核可和收購等策略來擴大產品系列。

目錄

第1章 簡介

第2章 執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響要素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 靜脈注射裝置的技術進步
      • 外科手術數量增加
      • 慢性病增加
    • 抑制因素
      • 嚴格的法規要求
    • 機會
      • 新興市場的成長機會
  • COVID-19 市場影響分析

第4章 靜脈器材市場：依產品類型

  • 概述
  • 點滴導管
  • 點滴幫浦
  • 給藥套件
    • 給藥套件靜脈器械市場：按套件類型
  • 無針頭連接器
  • 其他

第5章 靜脈器械市場：依最終用戶分類

  • 概述
  • 醫院和診所
  • 居家醫療
  • 其他

第6章 靜脈器材市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲、中東、非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第7章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第8章 公司簡介

  • Becton, Dickinson and Company
  • B. Braun SE
  • ICU Medical, Inc.
  • Baxter International Inc.
  • Teleflex Incorporated.
  • 3M Company
  • AngioDynamics, Inc.
  • Terumo Corporation
  • Poly Medicure Ltd.
  • Vygon
Product Code: A10856

According to a new report published by Allied Market Research, titled, "Intravenous Equipment Market," The intravenous equipment market was valued at $15.0 billion in 2022, and is estimated to reach $26.7 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.

Intravenous Equipment Market - IMG1

Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing's that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.

The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.

Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.

Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.

The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous equipment market analysis from 2022 to 2032 to identify the prevailing intravenous equipment market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intravenous equipment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intravenous equipment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product Type

  • IV catheters
  • Infusion pumps
  • Administration sets
    • Type of set
    • Solution administration sets
    • Blood administration sets.
  • Needleless connectors
  • Others

By End User

  • Hospitals and clinics
  • Homecare settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • AngioDynamics, Inc.
    • Becton, Dickinson and Company
    • Vygon
    • 3M Company
    • Terumo Corporation
    • Poly Medicure Ltd.
    • B. Braun SE
    • ICU Medical, Inc.
    • Baxter International Inc.
    • Teleflex Incorporated.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. High bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Technological advancements in intravenous equipment
      • 3.4.1.2. Growing number of surgical procedures
      • 3.4.1.3. Growing prevalence of chronic diseases
    • 3.4.2. Restraints
      • 3.4.2.1. Stringent regulatory requirements
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. IV catheters
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Infusion pumps
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Administration sets
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Administration sets Intravenous Equipment Market by Type of set
  • 4.5. Needleless connectors
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals and clinics
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Homecare settings
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Product Type
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Product Type
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Product Type
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Product Type
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Product Type
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Product Type
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Product Type
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Product Type
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Product Type
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Product Type
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Product Type
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Product Type
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Product Type
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. China
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Product Type
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Product Type
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Product Type
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Product Type
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Product Type
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Product Type
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Product Type
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Product Type
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Product Type
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Product Type
      • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Becton, Dickinson and Company
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. B. Braun SE
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
  • 8.3. ICU Medical, Inc.
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Baxter International Inc.
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Teleflex Incorporated.
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
  • 8.6. 3M Company
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
  • 8.7. AngioDynamics, Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
  • 8.8. Terumo Corporation
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Poly Medicure Ltd.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
  • 8.10. Vygon
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL ADMINISTRATION SETS INTRAVENOUS EQUIPMENT MARKET, BY TYPE OF SET, 2022-2032 ($MILLION)
  • TABLE 06. INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 09. INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. INTRAVENOUS EQUIPMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 16. U.S. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. U.S. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. CANADA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. CANADA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. UK INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. ITALY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. ITALY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. CHINA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. CHINA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. INDIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 64. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 65. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 66. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 67. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 68. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 69. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 70. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 71. ICU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 72. ICU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 73. ICU MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 74. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 75. ICU MEDICAL, INC.: KEY STRATERGIES
  • TABLE 76. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 77. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 78. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 79. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 80. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 81. TELEFLEX INCORPORATED.: KEY EXECUTIVES
  • TABLE 82. TELEFLEX INCORPORATED.: COMPANY SNAPSHOT
  • TABLE 83. TELEFLEX INCORPORATED.: PRODUCT SEGMENTS
  • TABLE 84. TELEFLEX INCORPORATED.: PRODUCT PORTFOLIO
  • TABLE 85. 3M COMPANY: KEY EXECUTIVES
  • TABLE 86. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 87. 3M COMPANY: PRODUCT SEGMENTS
  • TABLE 88. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 89. ANGIODYNAMICS, INC.: KEY EXECUTIVES
  • TABLE 90. ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • TABLE 91. ANGIODYNAMICS, INC.: PRODUCT SEGMENTS
  • TABLE 92. ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO
  • TABLE 93. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 94. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 95. TERUMO CORPORATION: PRODUCT SEGMENTS
  • TABLE 96. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 97. POLY MEDICURE LTD.: KEY EXECUTIVES
  • TABLE 98. POLY MEDICURE LTD.: COMPANY SNAPSHOT
  • TABLE 99. POLY MEDICURE LTD.: PRODUCT SEGMENTS
  • TABLE 100. POLY MEDICURE LTD.: PRODUCT PORTFOLIO
  • TABLE 101. VYGON: KEY EXECUTIVES
  • TABLE 102. VYGON: COMPANY SNAPSHOT
  • TABLE 103. VYGON: PRODUCT SEGMENTS
  • TABLE 104. VYGON: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. INTRAVENOUS EQUIPMENT MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF INTRAVENOUS EQUIPMENT MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN INTRAVENOUS EQUIPMENT MARKET (2023-2032)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. LOW INTENSITY OF RIVALRY
  • FIGURE 08. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL INTRAVENOUS EQUIPMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. INTRAVENOUS EQUIPMENT MARKET BY REGION, 2022(%)
  • FIGURE 21. U.S. INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. CANADA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. MEXICO INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. GERMANY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. FRANCE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. ITALY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. JAPAN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CHINA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. INDIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. BRAZIL INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: INTRAVENOUS EQUIPMENT MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
  • FIGURE 47. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 48. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 50. B. BRAUN SE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. ICU MEDICAL, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 54. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 60. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. ANGIODYNAMICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. ANGIODYNAMICS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 64. ANGIODYNAMICS, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 66. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. POLY MEDICURE LTD.: NET REVENUE, 2020-2022 ($MILLION)